DB18960InvestigationalSmall molecule
Dalosirvat is under investigation in clinical trial NCT03742518 (A Study Evaluating the Efficacy and Safety of SM04554 Topical Solution in Male Subjects With Androgenetic Alopecia).
- Formula / weight
- C18H16O4 · 296.322 g/mol (avg)
- Also known as
- 1-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-phenyl-butane-1,4-dione · 1-(2,3-dihydro-benzo(1,4)dioxin-6-yl)-4-phenyl-butane-1,4-dione · 1,4-butanedione, 1-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-phenyl-
- Code names
- SM-04554
Resolves to
Structure
InChIKey
AOCDRSSVFUCURK-UHFFFAOYSA-NSMILESO=C(CCC(=O)C1=CC=C2OCCOC2=C1)C1=CC=CC=C1What you can answer from here — as of April 23, 2025
Which companies are running trials of Dalosirvat, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account